The program is still filling in: some talks have no title yet and more speakers will be added. We’ll add new sessions, the organizations presenting them and stand numbers once the floor plan is published.

Genentech at Festival of Biologics USA 2027

Apr 13–14, 2027 Boston, MA ~2k attendees Website

Genentech takes part in 2 sessions at Festival of Biologics USA 2027 in Boston. Its sessions focus on cancer immunotherapy that works through T cells. They cover the costimulatory receptors CD28 and 4-1BB and a high-throughput automated assay for characterizing T cell-engaging bispecifics and combination therapies.

Organization	Festival of Biologics USA 2027 Attendance
Genentech South San Francisco, CA
gene.com Large pharma Biotechnology company in the Roche Group developing medicines for cancer, immunology, neuroscience and other serious diseases.	Talk Tue Apr 13 15:10 Exploring costimulatory receptors CD28 and 4-1BB for cancer immunotherapy Antibodies for Immunotherapy Talk Wed Apr 14 13:20 Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Protein Engineering

Instantly find 20 buyers from Genentech

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Festival of Biologics or its organizers. Submit a correction